NF-κB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter

Biochemical and Biophysical Research Communications

Volumn 382, Issue 2, 2009, Pages 269-273

  Borghaei, Ruth C ^a   Gorski, Grzegorz ^a   Javadi, Masoud ^a  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

Matrix metalloproteinase; NF B; Polymorphism; Stromelysin 1; Transcription factor; ZBP 89; ZNF148

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STROMELYSIN; UNCLASSIFIED DRUG; ZINC BINDING PROTEIN; ZINC BINDING PROTEIN 89; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR; ZNF148 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN COS1; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME REGULATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; ANIMAL; CERCOPITHECUS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASE 3; NF-KAPPA B; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 63349087447     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.002     Document Type: Article

References (39)

1. Ryan M.E., and Golub L.M. Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontology 24 (2000) 226-238
2. Parsons S.L., Watson S.A., Brown P.D., Collins H.M., and Steele R.J. Matrix metalloproteinases. Br. J. Surg. 84 (1997) 160-166
3. Murphy G., Cockett M.I., Stephens P.E., Smith B.J., and Docherty A.J. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem. J. 248 (1987) 265-268
4. Ogata Y., Enghild J.J., and Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267 (1992) 3581-3584
5. Suzuki K., Enghild J.J., Morodomi T., Salvesen G., and Nagase H. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29 (1990) 10261-10270
6. Lijnen H.R., Arza B., Van Hoef B., Collen D., and Declerck P.J. Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3). J. Biol. Chem. 275 (2000) 37645-37650
7. Matsuno H., Yudoh K., Watanabe Y., Nakazawa F., Aono H., and Kimura T. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J. Rheumatol. 28 (2001) 22-28
8. Noe V., Fingleton B., Jacobs K., Crawford H.C., Vermeulen S., Steelant W., Bruyneel E., Matrisian L.M., and Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 114 (2001) 111-118
9. Borghaei R.C., Sullivan C., and Mochan E. Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3). J. Biol. Chem. 274 (1999) 2126-2131
10. Ye S., Eriksson P., Hamsten A., Kurkinen M., Humphries S.E., and Henney A.M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J. Biol. Chem. 271 (1996) 13055-13060
11. Deguara J., Burnand K.G., Berg J., Green P., Lewis C.M., Chinien G., Waltham M., Taylor P., Stern R.F., Solomon E., and Smith A. An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. Hum. Mol. Genet. 16 (2007) 3002-3007
12. Holliday D.L., Hughes S., Shaw J.A., Walker R.A., and Jones J.L. Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Res. 9 (2007) R67
13. Lichtinghagen R., Bahr M.J., Wehmeier M., Michels D., Haberkorn C.I., Arndt B., Flemming P., Manns M.P., and Boeker K.H. Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and HCV-induced liver cirrhosis. Clin. Sci. (Lond.) 105 (2003) 373
14. Medley T.L., Kingwell B.A., Gatzka C.D., Pillay P., and Cole T.J. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ. Res. 92 (2003) 1254-1261
15. Abilleira S., Bevan S., and Markus H.S. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J. Med. Genet. 43 (2006) 897-901
16. Astolfi C.M., Shinohara A.L., da Silva R.A., Santos M.C., Line S.R., and de Souza A.P. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. J. Clin. Periodontol. 33 (2006) 699-703
17. Liu P.Y., Li Y.H., Tsai W.C., Tsai L.M., Chao T.H., Wu H.L., and Chen J.H. Stromelysin-1 promoter 5A/6A polymorphism is an independent genetic prognostic risk factor and interacts with smoking cessation after index premature myocardial infarction. J. Thromb. Haemost. 3 (2005) 1998-2005
18. Mora B., Bonamico M., Ferri M., Megiorni F., Osborn J., Pizzuti A., and Mazzilli M.C. Association of the matrix metalloproteinase-3 (MMP-3) promoter polymorphism with celiac disease in male subjects. Hum. Immunol. 66 (2005) 716-720
19. Okamoto K., Mimura K., Murawaki Y., and Yuasa I. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J. Gastroenterol. Hepatol. 20 (2005) 1102-1108
20. Takahashi M., Haro H., Wakabayashi Y., Kawa-uchi T., Komori H., and Shinomiya K. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J. Bone Joint Surg. Br. 83 (2001) 491-495
21. Vairaktaris E., Yapijakis C., Vasiliou S., Derka S., Nkenke E., Serefoglou Z., Vorris E., Vylliotis A., Ragos V., Neukam F.W., and Patsouris E. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer. Anticancer Res. 27 (2007) 4095-4100
22. Beyzade S., Zhang S., Wong Y.K., Day I.N., Eriksson P., and Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J. Am. Coll. Cardiol. 41 (2003) 2130-2137
23. Ye S., Whatling C., Watkins H., and Henney A. Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89. FEBS Lett. 450 (1999) 268-272
24. Borghaei R.C., Rawlings Jr. P.L., Javadi M., and Woloshin J. NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem. Biophys. Res. Commun. 316 (2004) 182-188
25. Nowak D.E., Tian B., and Brasier A.R. Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. Biotechniques 39 (2005) 715-725
26. Mattey D.L., Nixon N.B., Dawes P.T., Ollier W.E., and Hajeer A.H. Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun. 5 (2004) 147-149
27. Samnegard A., Silveira A., Lundman P., Boquist S., Odeberg J., Hulthe J., McPheat W., Tornvall P., Bergstrand L., Ericsson C.G., Hamsten A., and Eriksson P. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction. J. Intern. Med. 258 (2005) 411-419
28. White A.J., Duffy S.J., Walton A.S., Ng J.F., Rice G.E., Mukherjee S., Shaw J.A., Jennings G.L., Dart A.M., and Kingwell B.A. Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc. Res. 75 (2007) 813-820
29. Oceandy D., Yusoff R., Baudoin F.M., Neyses L., and Ray S.G. Promoter polymorphism of the matrix metalloproteinase 3 gene is associated with regurgitation and left ventricular remodelling in mitral valve prolapse patients. Eur. J. Heart Fail. 9 (2007) 1010-1017
30. Meijer M.J., Mieremet-Ooms M.A., van Hogezand R.A., Lamers C.B., Hommes D.W., and Verspaget H.W. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J. Gastroenterol. 13 (2007) 2960-2966
31. Nanni S., Melandri G., Hanemaaijer R., Cervi V., Tomasi L., Altimari A., Van Lent N., Tricoci P., Bacchi L., and Branzi A. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms. Transl. Res. 149 (2007) 137-144
32. Zhu C., Odeberg J., Hamsten A., and Eriksson P. Allele-specific MMP-3 transcription under in vivo conditions. Biochem. Biophys. Res. Commun. 348 (2006) 1150-1156
33. Bond M., Chase A.J., Baker A.H., and Newby A.C. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc. Res. 50 (2001) 556-565
34. Bondeson J., Lauder S., Wainwright S., Amos N., Evans A., Hughes C., Feldmann M., and Caterson B. Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent. J. Rheumatol. 34 (2007) 523-533
35. Bai L., Logsdon C., and Merchant J.L. Regulation of epithelial cell growth by ZBP-89: potential relevance in pancreatic cancer. Int. J. Gastrointest. Cancer 31 (2002) 79-88
36. Bai L., and Merchant J.L. ZBP-89 promotes growth arrest through stabilization of p53. Mol. Cell. Biol. 21 (2001) 4670-4683
37. Bai L., and Merchant J.L. Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells. J. Biol. Chem. 275 (2000) 30725-30733
38. Dawson M.I., Park J.H., Chen G., Chao W., Dousman L., Waleh N., Hobbs P.D., Jong L., Toll L., Zhang X., Gu J., Agadir A., Merchant J.L., Bai L., Verma A.K., Thacher S.M., Chandraratna R.A., Shroot B., and Hill D.L. Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition. Int. J. Cancer 91 (2001) 8-21
39. Chupreta S., Brevig H., Bai L., Merchant J.L., and Iniguez-Lluhi J.A. Sumoylation-dependent control of homotypic and heterotypic synergy by the Kruppel-type zinc finger protein ZBP-89. J. Biol. Chem. 282 (2007) 36155-36166